This company listing is no longer active
Apollo Endosurgery Management
Management Kriterienprüfungen 3/4
Wichtige Informationen
Chas McKhann
Geschäftsführender
US$2.8m
Gesamtvergütung
Prozentsatz des Geschäftsführergehalts | 19.8% |
Amtszeit als Geschäftsführer | 2.1yrs |
Eigentum des Geschäftsführers | 0.4% |
Durchschnittliche Amtszeit des Managements | 4.3yrs |
Durchschnittliche Amtszeit der Vorstandsmitglieder | 5.2yrs |
Jüngste Management Updates
Recent updates
Analyse der Geschäftsführervergütung
Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
---|---|---|---|
Dec 31 2022 | US$3m | US$550k | -US$40m |
Sep 30 2022 | n/a | n/a | -US$41m |
Jun 30 2022 | n/a | n/a | -US$36m |
Mar 31 2022 | n/a | n/a | -US$28m |
Dec 31 2021 | US$9m | US$375k | -US$25m |
Vergütung im Vergleich zum Markt: Chas's total compensation ($USD2.78M) is above average for companies of similar size in the German market ($USD886.27K).
Entschädigung vs. Einkommen: Chas's compensation has been consistent with company performance over the past year.
Geschäftsführer
Chas McKhann (53 yo)
2.1yrs
Amtszeit
US$2,780,544
Vergütung
Mr. Charles S. McKhann, also known as Chas, serves as President, Chief Executive Officer and Director at Apollo Endosurgery, Inc since March 01, 2021. He served as Chief Commercial Officer at Torax Medical...
Führungsteam
Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
---|---|---|---|---|
CEO, President & Director | 2.1yrs | US$2.78m | 0.39% $ 2.1m | |
CFO, Secretary & Treasurer | 1.7yrs | US$1.34m | 0.18% $ 951.6k | |
Executive Vice President of Operations | 5yrs | US$662.23k | 0.079% $ 422.7k | |
Co-Founder and Innovation Partner | no data | keine Daten | keine Daten | |
Co-Founder and Innovation Partner | no data | keine Daten | keine Daten | |
Co-Founder and Innovation Partner | no data | keine Daten | keine Daten | |
Co-Founder and Innovation Partner | 18.3yrs | keine Daten | keine Daten | |
Co-Founder & Chief Medical Officer | no data | US$1.16m | 0.062% $ 331.3k | |
Co-Founder and Innovation Partner | no data | keine Daten | keine Daten | |
Co-Founder | 18.3yrs | keine Daten | keine Daten | |
Investor Relations Manager | no data | keine Daten | keine Daten | |
Vice President of Legal & Compliance | 3.6yrs | keine Daten | keine Daten |
4.3yrs
Durchschnittliche Betriebszugehörigkeit
53yo
Durchschnittliches Alter
Erfahrenes Management: HQ8F's management team is considered experienced (4.3 years average tenure).
Vorstandsmitglieder
Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
---|---|---|---|---|
CEO, President & Director | 2.1yrs | US$2.78m | 0.39% $ 2.1m | |
Independent Chairman of the Board | 4.1yrs | US$193.24k | 0.051% $ 273.8k | |
Independent Director | 4.9yrs | US$164.49k | 0.038% $ 199.9k | |
Independent Director | 11.3yrs | US$165.15k | keine Daten | |
Independent Director | 8.9yrs | US$169.49k | 0.047% $ 247.9k | |
Member of Scientific Advisory Board | no data | keine Daten | keine Daten | |
Member of Scientific Advisory Board | no data | keine Daten | keine Daten | |
Member of Scientific Advisory Board | no data | keine Daten | keine Daten | |
Member of Scientific Advisory Board | no data | keine Daten | keine Daten | |
Member of Scientific Advisory Board | no data | keine Daten | keine Daten | |
Member of Scientific Advisory Board | no data | keine Daten | keine Daten | |
Independent Director | 5.4yrs | US$159.70k | 0.0067% $ 35.7k |
5.2yrs
Durchschnittliche Betriebszugehörigkeit
58.5yo
Durchschnittliches Alter
Erfahrener Vorstand: HQ8F's board of directors are considered experienced (5.2 years average tenure).